Navigation Links
Pharmos Corporation Announces Board and Management Changes
Date:1/3/2008

yte), ExSAR and Targent.

Mr. Johnston served as CEO of Cytogen from July 1988 to April 1989. He is also a member of the Advisory Council of the Department of Molecular Biology at Princeton University and the Executive Committee of the Friends of the Institute for Advanced Study in Princeton, as well as Founder and President of Educational Ventures, a foundation focused on funding improvements in the educational system; and Vice-Chairman of Center for Education Reform (CER) an advocate for charter schools. Mr. Johnston received his B.A. from Princeton University and his M.B.A. from New York University.

S. Colin Neill

S. Colin Neill who becomes President of the Company, became Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos in October 2006. From September 2003 to October 2006, Mr. Neill served as Chief Financial Officer, Treasurer and Secretary of Axonyx, Inc. a biopharmaceutical company that developed products and technologies to treat Alzheimer's disease and other central nervous system disorders, where he played an integral role in the merger between Axonyx and TorreyPines Therapeutics Inc., a privately- held biopharmaceutical company. From 1998 to 2001, Mr. Neill served as Senior Vice President, Chief Financial Officer, Secretary and Treasurer of ClinTrials Research Inc., a $100 million publicly traded global contract research organization in the drug development business. Mr. Neill played a key role in the successful sale of the company in 2001. Mr. Neill graduated from Trinity College, Dublin with a first class honors degree in Business / Economics and he holds a masters degree in Accounting and Finance from the London School of Economics. He is a Certified Public Accountant in New York State and a Chartered Accountant in Ireland.

About Pharmos Corporation

Pharmos Corporation is a biopharmaceutical company that discovers and develops novel therapeutics to treat a range of diseases of the nervo
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
2. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
3. Pharmos Corporation Reports 2007 Third Quarter Results
4. Pharmos Issues Letter to Shareholders
5. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
6. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
7. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
10. FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products
11. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Drug safety specialty firm Bio...ning and Informatics earned the Certified Professi...dential from the American Society for Training and...elle Flewell has more than fifteen years of medica...ce and is responsible for the development of the c...
(Date:11/5/2009)... Brooke Sanders brings a new lo... CA (PRWEB) November 5, 2009 -- Professional Repro...prographics company is pleased to present Brooke S... their graphics/PR specialist. The addition of Bro...tent growth within Professional Reprographics., , ...
(Date:11/4/2009)... The Human Anthrax Vaccine Prog... completed the feature film "A Call to Arms:2...mentary "Fatal Immunity: The Human Anthrax Va...lear and present danger of top secret government s...es with no accountability to its victims. It is a...
(Date:11/4/2009)...PETERSBURG, Va., Nov. 4 ...ed today that the company plans to introduce the C...bsidiary, Rock Creek Pharmaceuticals, for worldwid...iv Health, Inc . (Nasdaq: VTIV). inVentiv Health...tions for every stage of the product lifecycle, in...
Breaking Biology Technology:BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4
... Inc. (Nasdaq and SWX: BMRN) announced today that ...idiary of Daiichi Sankyo),exclusive rights to data...TM) (sapropterin dihydrochloride) new drug applica...t its current filing to the Japanese,Ministry of H...product for,the treatment of phenylketonuria (PKU)...
...otech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: A...agreement with Johnson & Johnson,s subsidiary, Con...patent litigation with respect to Conor,s,CoStar(R...lace, Angiotech expects that the resources,require...should decrease,",said Dr. William Hunter, Preside...
... (Nasdaq: KERX ) today announced that I. Craig He... an overview of the Company,s cancer,pipeline at t... Conference,in San Francisco. Dr. Henderson,s pres...9th at 8:30 am PT. Dr. Henderson,s presentation w...e Investor Information page of the Company,s Websi...
Other Biology Technology:Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 2Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 3Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan 4Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 2Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 4Keryx Biopharmaceuticals to Present at Bank of America Investment Conference 2
(Date:11/8/2009)...09) The loss of a gene through deletion of geneti...nificant abnormalities in learning and behavior, s...ege of Medicine ( www.bcm.edu ) in a report that a...s . , "This research goes about 95 percent of th...p of individuals to this gene," said Dr. Arthur L....
(Date:11/6/2009)...ally live in harmony with their arboreal hosts. Bu...space in their trees of choice, the ants can get d... published in the November issue of the American ...re into live trees, and it reopens a centuries-old...s. , Ants and certain species of plants and tree...
(Date:11/5/2009)...ers at Yale University have developed synthetic mo...ponse to HIV and HIV-infected cells, as well as to...online in the Journal of the American Chemical So... for these diseases. , The molecules called "a... and "antibody-recruiting molecule targeting prost...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 1Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 2Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 3Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 4Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 5Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO ESMO Congress 2009 5015 6Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 1Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 2The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 1The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 2
...elease is available in German . , Leipzig. Fallo... are evidently capable of having a much greater ef...umed. This is the conclusion drawn by researchers ...hed fields in southern Ukraine and led to extremel...tral Europe. On 24 March 2007 the dust cloud sprea...
...of young schoolchildren from a remote Siberian vil...play at the American Association for the Advanceme...W, Washington, D.C. , The children, who are 9-14...uestions from the audience via a videoteleconferen...orium. The works, mainly watercolors and some char...
...eak of the insidious screw worm fly in Yemen, is t... livestock is a traditional way of life. In recent...n Vienna, Austria, to turn to the international co...ly pest. , The menacing fly lays its eggs in a cu...ots then feast off the living flesh, and can kill ...
Other Biology News:Arable land can have a negative impact on air quality 2Arable land can have a negative impact on air quality 3Arable land can have a negative impact on air quality 4Arable land can have a negative impact on air quality 5May 14 AAAS Lecture and videoteleconference on artworks by Siberian schoolchildren 2Screw worm outbreak in Yemen 2Screw worm outbreak in Yemen 3
... offers 144 highly successful analytical technique...nd tested protocol contains detailed, step-by-step...ernative procedures, informative explanations and ...ics covered range from protein and peptide electro...
... homogeneous and gradient polyacrylamide gels.Sepa...and isoelectric focusing gels.Save time and improv..., and staining kits.Achieve detection sensitivity ...use silver staining kits. Category: Electrophoresi...
Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Rhesus Serum from Innovative Research
Biology Products: